U.S. markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
21.83+0.93 (+4.45%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
30,744
33,215
34,505
28,267
32,100
Operating Expense
134,508
121,345
104,889
128,551
123,495
Operating Income
-103,764
-88,130
-70,384
-100,284
-91,395
Net Non Operating Interest Income Expense
-1,151
-1,978
531
1,172
1,590
Other Income Expense
204
981
-426
170
425
Pretax Income
-104,711
-89,127
-70,279
-98,942
-89,380
Net Income Common Stockholders
-104,711
-89,127
-70,279
-98,942
-89,380
Diluted NI Available to Com Stockholders
-104,711
-89,127
-70,279
-98,942
-89,380
Basic EPS
-
-1.12
-1.24
-2.43
-2.21
Diluted EPS
-
-1.12
-1.24
-2.43
-2.21
Basic Average Shares
-
79,789
56,649
40,743
40,449
Diluted Average Shares
-
79,789
56,649
40,743
40,449
Total Operating Income as Reported
-103,764
-88,130
-71,876
-100,284
-91,395
Total Expenses
134,508
121,345
104,889
128,551
123,495
Net Income from Continuing & Discontinued Operation
-104,711
-89,127
-70,279
-98,942
-89,380
Normalized Income
-104,711
-89,127
-68,787
-98,942
-89,380
Interest Income
1,753
946
1,033
-
-
Interest Expense
2,904
2,924
502
-
-
Net Interest Income
-1,151
-1,978
531
1,172
1,590
EBIT
-101,807
-86,203
-69,777
-100,284
-91,395
EBITDA
-95,555
-
-
-
-
Reconciled Depreciation
6,252
6,578
7,603
7,862
7,259
Net Income from Continuing Operation Net Minority Interest
-104,711
-89,127
-70,279
-98,942
-89,380
Total Unusual Items Excluding Goodwill
0
0
-1,492
-
425
Total Unusual Items
0
0
-1,492
-
425
Normalized EBITDA
-95,555
-79,625
-60,682
-92,422
-84,136
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more